Skip to main content

30.11.2019 | Obesity and Nutrition (O Pickett-Blakely, Section Editor)

Beyond the Calories—Is the Problem in the Processing?

verfasst von: Janese Laster, MD, Leigh A. Frame, PhD, MHS

Erschienen in: Current Treatment Options in Gastroenterology

Einloggen, um Zugang zu erhalten

Abstract

Purpose of review

The purpose of this review is to describe the trends in dietary patterns and food quality over time along with the possible role of ultra-processed foods in obesity, chronic diseases, and all-cause mortality in the US population.

Recent findings

There is a rising obesity epidemic, corresponding chronic diseases, and increases in ultra-processed food consumption. In mice and in vitro trials, emulsifiers, found in processed foods, have been found to alter microbiome compositions, elevate fasting blood glucose, cause hyperphagia, increase weight gain and adiposity, and induce hepatic steatosis. Recent human trials have found ultra-processed foods as a contributor to decreased satiety, increased meal eating rates, worsening biochemical markers, and more weight gain. In contrast, Blue Zone, indigenous South American, and Mediterranean populations with low meat intake, high fiber, and minimally processed foods have far less chronic diseases, obesity rates, and live longer disease-free.

Summary

As the USA continues to industrialize, food has become more processed and cheaper and more convenient along with the coexistent rise in obesity prevalence. This review highlights the overall trends in food: mild improvements in dietary quality in higher socioeconomic populations, but no significant increases in whole fruit, vegetables, legumes, or nuts. Consumption of ultra-processed food is associated with weight gain and may contribute to metabolic syndrome and chronic disease. To combat this epidemic, we must create and disseminate detailed recommendations to improve diet quality and overall nutrition.
Literatur
1.
3.
Zurück zum Zitat Keith SW, Redden DT, Katzmarzyk PT, et al. Putative contributors to the secular increase in obesity: exploring the roads less traveled. Int J Obes. 2006;30:1585–94.CrossRef Keith SW, Redden DT, Katzmarzyk PT, et al. Putative contributors to the secular increase in obesity: exploring the roads less traveled. Int J Obes. 2006;30:1585–94.CrossRef
4.
Zurück zum Zitat Singh RK, Ishikawa S. Food additive P-80 impacts mouse gut microbiota promoting intestinal inflammation, obesity, and liver dysfunction. SOJ Microbioal Infec Dis. 2016;4(1):1–10.CrossRef Singh RK, Ishikawa S. Food additive P-80 impacts mouse gut microbiota promoting intestinal inflammation, obesity, and liver dysfunction. SOJ Microbioal Infec Dis. 2016;4(1):1–10.CrossRef
5.
Zurück zum Zitat Swinburn BA, Sacks G, Hall KD, et al. The global obesity pandemic: shaped by global drivers and local environments. Lance. 2011;378:804–14.CrossRef Swinburn BA, Sacks G, Hall KD, et al. The global obesity pandemic: shaped by global drivers and local environments. Lance. 2011;378:804–14.CrossRef
6.
Zurück zum Zitat Jeaon JY, Ha KW, Kim DJ. New risk factors for obesity and diabetes: Environmental chemicals. J Diabetes Investig. 2015;6(2):109–11.CrossRef Jeaon JY, Ha KW, Kim DJ. New risk factors for obesity and diabetes: Environmental chemicals. J Diabetes Investig. 2015;6(2):109–11.CrossRef
7.
Zurück zum Zitat Lenard NR, Berthoud HR. Central and Peripheral regulation of food intake and physical activity: pathways and genes. Obesity. 2008;16(Suppl3):S11–22.CrossRef Lenard NR, Berthoud HR. Central and Peripheral regulation of food intake and physical activity: pathways and genes. Obesity. 2008;16(Suppl3):S11–22.CrossRef
8.
Zurück zum Zitat Makris MC, Alexandrou A, Papatsoutsos EG, et al. Ghrelin and obesity: Identifying gaps and dispelling myths. A reappraisal. In vivo. 2017;31:1047–50.PubMedPubMedCentral Makris MC, Alexandrou A, Papatsoutsos EG, et al. Ghrelin and obesity: Identifying gaps and dispelling myths. A reappraisal. In vivo. 2017;31:1047–50.PubMedPubMedCentral
9.
Zurück zum Zitat Flegal K, Kruszon-Moran D, Carroll M, et al. Trends in obesity among adults in the Unites States, 2005–2014. JAMA. 2016;315(21):2284–91.CrossRef Flegal K, Kruszon-Moran D, Carroll M, et al. Trends in obesity among adults in the Unites States, 2005–2014. JAMA. 2016;315(21):2284–91.CrossRef
10.
Zurück zum Zitat Mozaffarian D, Hao T, Rimm T, Willet W, Hu F. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med. 2011;364(25):2392–404.CrossRef Mozaffarian D, Hao T, Rimm T, Willet W, Hu F. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med. 2011;364(25):2392–404.CrossRef
11.
Zurück zum Zitat Monterio CA, et al. Household availability of ultra-processed foods and obesity in nineteen European countries. Public Health Nutr. 21(1):18–26. Monterio CA, et al. Household availability of ultra-processed foods and obesity in nineteen European countries. Public Health Nutr. 21(1):18–26.
12.
Zurück zum Zitat Rehm C, Penalvo J, Afshin A, Mozaffarian D. Dietary intake among US adults, 199-2012. JAMA. 2016;315(23):2542–53.CrossRef Rehm C, Penalvo J, Afshin A, Mozaffarian D. Dietary intake among US adults, 199-2012. JAMA. 2016;315(23):2542–53.CrossRef
13.
Zurück zum Zitat Wang D, Leung C, Li Y, Ding E, Chiuve S, Hu F, et al. Trends in dietary quality among adults in the United States, 1999 through 2010. JAMA. 2014;174(10):1587–95. Wang D, Leung C, Li Y, Ding E, Chiuve S, Hu F, et al. Trends in dietary quality among adults in the United States, 1999 through 2010. JAMA. 2014;174(10):1587–95.
14.
Zurück zum Zitat US Department of Health and Human Services. Dietary guidelines for Americans 2015–2020. New York: Skyhorse Publishing Inc.; 2017. US Department of Health and Human Services. Dietary guidelines for Americans 2015–2020. New York: Skyhorse Publishing Inc.; 2017.
15.
Zurück zum Zitat Storey M, Anderson P. Income and race/ethnicity influence dietary fiber intake and vegetable consumption. Nutr Res. 2014;34(10):844–50.CrossRef Storey M, Anderson P. Income and race/ethnicity influence dietary fiber intake and vegetable consumption. Nutr Res. 2014;34(10):844–50.CrossRef
16.
Zurück zum Zitat Veronese N, Solmi M, Caruso MG, et al. Dietary fiber and health outcomes: an umbrella review of systematic reviews and meta-analyses. Am J Clin Nutr. 2018;107(3):436–44.CrossRef Veronese N, Solmi M, Caruso MG, et al. Dietary fiber and health outcomes: an umbrella review of systematic reviews and meta-analyses. Am J Clin Nutr. 2018;107(3):436–44.CrossRef
17.
Zurück zum Zitat North CJ, Venter CS, Jerling JC. The effects of dietary fibre on C-reactive protein, an inflammation marker predicting cardiovascular disease. Eur J Clin Nutr. 2009;63(8):921–33.CrossRef North CJ, Venter CS, Jerling JC. The effects of dietary fibre on C-reactive protein, an inflammation marker predicting cardiovascular disease. Eur J Clin Nutr. 2009;63(8):921–33.CrossRef
18.
Zurück zum Zitat Krishnamurthy VMR, Wei G, Baird BC, et al. High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease. Kidney Int. 2012;81(3):300.CrossRef Krishnamurthy VMR, Wei G, Baird BC, et al. High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease. Kidney Int. 2012;81(3):300.CrossRef
19.
Zurück zum Zitat Kuo S-M. The interplay between fiber and the intestinal microbiome in the inflammatory response. Adv Nutr. 2013;4(1):16–28.CrossRef Kuo S-M. The interplay between fiber and the intestinal microbiome in the inflammatory response. Adv Nutr. 2013;4(1):16–28.CrossRef
21.
Zurück zum Zitat Flint HJ. The impact of nutrition on the human microbiome. Nutr Rev. 2012;70:S10–3.CrossRef Flint HJ. The impact of nutrition on the human microbiome. Nutr Rev. 2012;70:S10–3.CrossRef
22.
Zurück zum Zitat Holscher HD. Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes. 2017;8(2):172–84.CrossRef Holscher HD. Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes. 2017;8(2):172–84.CrossRef
23.
Zurück zum Zitat Cummings JH, et al. Fecal weight, colon cancer risk, and dietary intake of nonstarch polysaccharides (dietary fiber). Gastroenterology. 1992:1783–9. Cummings JH, et al. Fecal weight, colon cancer risk, and dietary intake of nonstarch polysaccharides (dietary fiber). Gastroenterology. 1992:1783–9.
24.
Zurück zum Zitat Rose DJ, DeMeo MT, Keshavarzian A, et al. Influence of dietary fiber on inflammatory bowel disease and colon cancer: importance of fermentation pattern. Nutr Rev. 2007;65(2):51–62.CrossRef Rose DJ, DeMeo MT, Keshavarzian A, et al. Influence of dietary fiber on inflammatory bowel disease and colon cancer: importance of fermentation pattern. Nutr Rev. 2007;65(2):51–62.CrossRef
25.
Zurück zum Zitat Roca-Saavedra P, Mendez-Vilabrille V, Miranda JM, et al. Food additives, contaminants and other minor components: effects on human gut microbiota-a review. J Physiol Biochem. 2018;74(1):69–83.CrossRef Roca-Saavedra P, Mendez-Vilabrille V, Miranda JM, et al. Food additives, contaminants and other minor components: effects on human gut microbiota-a review. J Physiol Biochem. 2018;74(1):69–83.CrossRef
26.
Zurück zum Zitat Krajmalnik-Brown R, Ilhan ZE, Kang DW, DiBaise JK. Effects of gut microbes on nutrient absorption and energy regulation. Nutr Clin Pract. 2012;27(2):201–14.CrossRef Krajmalnik-Brown R, Ilhan ZE, Kang DW, DiBaise JK. Effects of gut microbes on nutrient absorption and energy regulation. Nutr Clin Pract. 2012;27(2):201–14.CrossRef
29.
Zurück zum Zitat Glade MJ, Meguid MM. A glance at dietary emulsifiers, the human intestinal mucus and microbiome, and dietary fiber. Nutrition. 2016;32:609–14.CrossRef Glade MJ, Meguid MM. A glance at dietary emulsifiers, the human intestinal mucus and microbiome, and dietary fiber. Nutrition. 2016;32:609–14.CrossRef
31.
Zurück zum Zitat Ogawa H, Rafiee P, Fisher PJ, Johnson NA, et al. Butyrate modulates gene and protein expression in human intestinal endothelial cells. Biochem Biophys Res Commun. 2003;309(3):512–9.CrossRef Ogawa H, Rafiee P, Fisher PJ, Johnson NA, et al. Butyrate modulates gene and protein expression in human intestinal endothelial cells. Biochem Biophys Res Commun. 2003;309(3):512–9.CrossRef
33.
Zurück zum Zitat •• Willet W, et al. Food in the Anthropocene: the Eat-Lancet Commission on healthy diets from sustainable food systems. Lancet. 2019;393(10170):447–92 This is a landmark trial describes the intricate worldwide factors that contribute to climate change, obesity, chronic diseases, animal extinction, and many other factors. CrossRef •• Willet W, et al. Food in the Anthropocene: the Eat-Lancet Commission on healthy diets from sustainable food systems. Lancet. 2019;393(10170):447–92 This is a landmark trial describes the intricate worldwide factors that contribute to climate change, obesity, chronic diseases, animal extinction, and many other factors. CrossRef
34.
Zurück zum Zitat Shah R, Kolanos R, et al. Dietary exposures for the safety assessment of seven emulsifiers commonly added to foods in the United States and implications for safety. Food Addit Contam. 2017;34(6):905–17.CrossRef Shah R, Kolanos R, et al. Dietary exposures for the safety assessment of seven emulsifiers commonly added to foods in the United States and implications for safety. Food Addit Contam. 2017;34(6):905–17.CrossRef
35.
Zurück zum Zitat •• Hall K, Ayuketah A, Brychta R, Cai H, Cassimatis T, Chen K, et al. Ultra-processed diets cause excess calorie intake and weight gain: an inpatient randomized controlled trial of ad libitum food intake. Cell Metabolism. 2019;30:1–11 This was the first inpatient trial to study the effects of unprocessed and processed diets in humans on weight, energy intake, biochemical markers, etc. CrossRef •• Hall K, Ayuketah A, Brychta R, Cai H, Cassimatis T, Chen K, et al. Ultra-processed diets cause excess calorie intake and weight gain: an inpatient randomized controlled trial of ad libitum food intake. Cell Metabolism. 2019;30:1–11 This was the first inpatient trial to study the effects of unprocessed and processed diets in humans on weight, energy intake, biochemical markers, etc. CrossRef
36.
Zurück zum Zitat • Chassaing B, Koren O, Goodrich J, et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature. 2015;519:92–9 This trial showed small bowel, inflammatory, microbiome, and biochemical changes due to emulsifier use in a mouse model. CrossRef • Chassaing B, Koren O, Goodrich J, et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature. 2015;519:92–9 This trial showed small bowel, inflammatory, microbiome, and biochemical changes due to emulsifier use in a mouse model. CrossRef
37.
Zurück zum Zitat Chassaing B, Van de Wiele T, De Bodt J, et al. Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation. Gut. 2017;66:1414–27.CrossRef Chassaing B, Van de Wiele T, De Bodt J, et al. Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation. Gut. 2017;66:1414–27.CrossRef
38.
Zurück zum Zitat Swidsinski A, Ung V, Sydora BC, Loening-Baucke V, et al. Bacterial overgrowth and inflammation of small intestine after carboxymethylcellulose ingestion in genetically susceptible mice. Inflamm Bowel Dis. 2009;15(3):359–64.CrossRef Swidsinski A, Ung V, Sydora BC, Loening-Baucke V, et al. Bacterial overgrowth and inflammation of small intestine after carboxymethylcellulose ingestion in genetically susceptible mice. Inflamm Bowel Dis. 2009;15(3):359–64.CrossRef
39.
Zurück zum Zitat Viennois E, Merlin D, Gewirtz AT, Chassaing B. Dietary emulsifier-induced low grade inflammation promotes colon carcinogenesis. Cancer Res. 2017;77:37–40.CrossRef Viennois E, Merlin D, Gewirtz AT, Chassaing B. Dietary emulsifier-induced low grade inflammation promotes colon carcinogenesis. Cancer Res. 2017;77:37–40.CrossRef
40.
Zurück zum Zitat Shang Q, Sun W, Shan X, et al. Carrageenan-induced colitis is associated with decreased population of anti-inflammatory bacterium, Akkermansia muciniphila, in the gut microbiota of C57BL/6J mice. Toxicol Lett. 2017;279:87–95.CrossRef Shang Q, Sun W, Shan X, et al. Carrageenan-induced colitis is associated with decreased population of anti-inflammatory bacterium, Akkermansia muciniphila, in the gut microbiota of C57BL/6J mice. Toxicol Lett. 2017;279:87–95.CrossRef
41.
Zurück zum Zitat Martinez Steele E, Raubenheimer D, et al. Ultra-processed foods, protein leverage and energy intake in the USA. Public Health Nutr. 2018;21:114–24.CrossRef Martinez Steele E, Raubenheimer D, et al. Ultra-processed foods, protein leverage and energy intake in the USA. Public Health Nutr. 2018;21:114–24.CrossRef
42.
Zurück zum Zitat Poti J, Braga B, Qin B. Ultra-processed food intake and obesity: what really matters for health-processing or nutrient content? Curr Obes Rep. 2017;6(4):420–31.CrossRef Poti J, Braga B, Qin B. Ultra-processed food intake and obesity: what really matters for health-processing or nutrient content? Curr Obes Rep. 2017;6(4):420–31.CrossRef
43.
Zurück zum Zitat Buettner D, Skemp S. Blue zones: lessons from the world’s longest lived. Am J Lifestyle Med. 2016;10(5):318–21.CrossRef Buettner D, Skemp S. Blue zones: lessons from the world’s longest lived. Am J Lifestyle Med. 2016;10(5):318–21.CrossRef
44.
Zurück zum Zitat Olich M, Singh P, Sabate J, et al. Vegetarian dietary patterns and mortality in Adventist Health Study 2. JAMA Intern Med. 2013 July 8;173(13):1230–8.CrossRef Olich M, Singh P, Sabate J, et al. Vegetarian dietary patterns and mortality in Adventist Health Study 2. JAMA Intern Med. 2013 July 8;173(13):1230–8.CrossRef
45.
Zurück zum Zitat Guasch-Ferré M, Salas-Salvadó J, Estruch R, Corella D, Fitó M. Martinez-González MA; PREDIMED Investigators. The PREDIMED trial, Mediterranean diet and health outcomes: how strong is the evidence? Nutr Metab Cardiovasc Dis. 2017;27(7):624–32.CrossRef Guasch-Ferré M, Salas-Salvadó J, Estruch R, Corella D, Fitó M. Martinez-González MA; PREDIMED Investigators. The PREDIMED trial, Mediterranean diet and health outcomes: how strong is the evidence? Nutr Metab Cardiovasc Dis. 2017;27(7):624–32.CrossRef
46.
Zurück zum Zitat Kaplan H, Thompson R, Truble B, Wann L, Allam A, et al. Coronary atherosclerosis in indigenous South American Tsimane: a cross-sectional cohort study. Lancet. 2017;389(10080):1730–9.CrossRef Kaplan H, Thompson R, Truble B, Wann L, Allam A, et al. Coronary atherosclerosis in indigenous South American Tsimane: a cross-sectional cohort study. Lancet. 2017;389(10080):1730–9.CrossRef
Metadaten
Titel
Beyond the Calories—Is the Problem in the Processing?
verfasst von
Janese Laster, MD
Leigh A. Frame, PhD, MHS
Publikationsdatum
30.11.2019
Verlag
Springer US
Erschienen in
Current Treatment Options in Gastroenterology
Print ISSN: 1092-8472
Elektronische ISSN: 1534-309X
DOI
https://doi.org/10.1007/s11938-019-00246-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.